3.4 Optimizing the Effectiveness of HIV Treatment as Prevention with Stimulant Users


REFERENCES


1. Cohen, M.S., Chen, Y.Q., McCauley, M., et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine, 365(6), 493–505. Epub 2011/07/20.


2. Montaner, J.S., Lima, V.D., Barrios, R., et al. (2010) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet, 376(9740), 532–539.


3. Hall HI, Holtgrave DR, Tang T, Rhodes P. HIV transmission in the United States: considerations of viral load, risk behavior, and health disparities. AIDS and Behavior. 2013, 17, 1632–1636.


4. Colfax, G., Santos, G.M., Chu, P., et al. (2010) Amphetamine-group substances and HIV. Lancet, 376(9739), 458–474. Epub 2010/07/24.


5. Scott, J.C., Woods, S.P., Matt, G.E., et al. (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychology Review, 17(3), 275–297.


6. Chang, L., Ernst, T., Speck, O., & Grob, C.S. (2005) Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. The American Journal of Psychiatry, 162(2), 361–369. Epub 2005/01/29.


7. Ostrow, D.G., Plankey, M.W., Cox, C., et al. (2009) Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. Journal of Acquired Immune Deficiency Syndromes, 51(3), 349–355. Epub 2009/04/24.


8. Meade, C.S., Watt, M.H., Sikkema, K.J., et al. (2012) Methamphetamine use is associated with childhood sexual abuse and HIV sexual risk behaviors among patrons of alcohol-serving venues in Cape Town, South Africa. Drug and Alcohol Dependence. 126(1–2), 232–239. Epub 2012/06/22.


9. Couture, M.C., Evans, J.L., Sothy, N.S., et al. (2012) Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Drug and Alcohol Dependence, 120(1–3), 119–126. Epub 2011/08/09.


10. Parry, C.D., Pluddemann, A., Myers, B., Wechsberg, W.M., & Flisher, A.J. (2011) Methamphetamine use and sexual risk behaviour in Cape Town, South Africa: a review of data from 8 studies conducted between 2004 and 2007. African Journal of Psychiatry, 14(5), 372–376. Epub 2011/12/21.


11. Kapp, C. (2008) Crystal meth boom adds to South Africa’s health challenges. Lancet, 371(9608), 193–194.


12. Pluddemann, A., Myers, B.J., & Parry, C.D. (2008) Surge in treatment admissions related to methamphetamine use in Cape Town, South Africa: implications for public health. Drug and Alcohol Review, 27(2), 185–189.


13. Carrico, A.W. (2011) Substance use and HIV disease progression in the HAART era: implications for the primary prevention of HIV. Life Sciences, 88(21–22), 940–947.


14.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 8, 2016 | Posted by in PSYCHIATRY | Comments Off on 3.4 Optimizing the Effectiveness of HIV Treatment as Prevention with Stimulant Users

Full access? Get Clinical Tree

Get Clinical Tree app for offline access